Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Press Release

    Press Release - Page 2

    Trivitron launches 4 novel Newborn Screening panels, Check out details

    Trivitron launches 4 novel Newborn Screening panels, Check out details

    Medical Dialogues Bureau19 Oct 2018 1:21 PM IST
    Bratislava, Slovakia: Trivitron’s Labsystems Diagnostics Oy, a leading brand that develops and manufactures high quality diagnostic tests for clinical...
    Bengaluru: Mylan Hackathon 2018 Winners announced

    Bengaluru: Mylan Hackathon 2018 Winners announced

    Medical Dialogues Bureau18 Oct 2018 11:18 AM IST
    BENGALURU: Mylan Pharmaceuticals Private Limited announced the winners of its second edition of the Mylan Hackathon held in Bengaluru. The two-day...
    Themis Bioscience Announces Exclusive Licensing Agreement with Max-Planck-Innovation for Oncolytic Virotherapies

    Themis Bioscience Announces Exclusive Licensing Agreement with Max-Planck-Innovation for Oncolytic Virotherapies

    Medical Dialogues Bureau14 Oct 2018 10:16 AM IST
    New Delhi: Themis announced that it has entered into a license agreement with Max-Planck-Innovation GmbH, the technology transfer agency of the Max...
    FDA approves Cassipa as maintenance treatment for opioid dependence

    FDA approves Cassipa as maintenance treatment for opioid dependence

    Ruby Khatun Khatun9 Sept 2018 10:00 AM IST
    The U.S. Food and Drug Administration (FDA) approved Cassipa (buprenorphine and naloxone) sublingual film (applied under the tongue) for the...
    Manipal Group buys strategic stake in Cigna TTK Health Insurance

    Manipal Group buys strategic stake in Cigna TTK Health Insurance

    Ruby Khatun Khatun3 Sept 2018 4:07 PM IST
    MUMBAI: Cigna TTK Health Insurance Company Limited (Cigna TTK) has received necessary regulatory approvals, from the Insurance Regulatory and...
    Sun Pharma launches Volini Maxx with Virat Kohli as brand ambassador

    Sun Pharma launches Volini Maxx with Virat Kohli as brand ambassador

    Ruby Khatun Khatun1 Sept 2018 10:00 AM IST
    Mumbai: Sun Pharma Consumer Healthcare, a division of Sun Pharmaceutical Industries Ltd announced the launch of Volini Maxx, India’s strongest pain...
    Lupin gets USFDA tentative approval for generic Nudovra

    Lupin gets USFDA tentative approval for generic Nudovra

    Ruby Khatun Khatun26 Aug 2018 11:00 AM IST
    Mumbai: Pharma major Lupin announced that it has received tentative approval for its Nudovra (Estradiol Valerate Tablets, 3 mg and 1 mg and Estradiol...
    FDA approves Oxervate for neurotrophic keratitis, a rare eye disease

    FDA approves Oxervate for neurotrophic keratitis, a rare eye disease

    Ruby Khatun Khatun25 Aug 2018 10:15 AM IST
    The U.S. Food and Drug Administration (FDA) approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare...
    FDA permits marketing of transcranial magnetic stimulation for obsessive compulsive disorder

    FDA permits marketing of transcranial magnetic stimulation for obsessive compulsive disorder

    Ruby Khatun Khatun22 Aug 2018 10:45 AM IST
    The U.S. Food and Drug Administration (FDA) permitted the marketing of the Brainsway Deep Transcranial Magnetic Stimulation System for the treatment...
    Mylan launches first generic for Adcirca tablets

    Mylan launches first generic for Adcirca tablets

    Ruby Khatun Khatun19 Aug 2018 9:45 AM IST
    HERTFORDSHIRE, England, and PITTSBURGH: Global pharmaceutical company Mylan N.V. announced the U.S. launch of Tadalafil Tablets USP, 20 mg, the first...
    FDA approves first generic version of EpiPen

    FDA approves first generic version of EpiPen

    Ruby Khatun Khatun18 Aug 2018 10:15 AM IST
    The U.S. Food and Drug Administration approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency...
    FDA approves new vaginal ring for one year of birth control

    FDA approves new vaginal ring for one year of birth control

    Ruby Khatun Khatun17 Aug 2018 10:00 AM IST
    The U.S. Food and Drug Administration (FDA) approved Annovera (segesterone acetate and ethinyl estradiol vaginal system), which is a combined hormonal...
    PrevNext

    Popular Stories

    Government to frame new rules on medical devices to draw investments

    Government to frame new rules on medical devices to draw investments

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Healthcare sector adversely impacted due to NPPA regulatory measures: ICRA

    Healthcare sector adversely impacted due to NPPA regulatory measures: ICRA

    FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

    FDA expands approval of Gilenya to treat multiple sclerosis in pediatric patients

    BA/BE study applications have to be processed in 15 days: CDSCO

    BA/BE study applications have to be processed in 15 days: CDSCO

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Bayer appoints Bijoy Sagar as new Chief Information Technology & Digital Transformation Officer

    Bayer appoints Bijoy Sagar as new Chief Information Technology & Digital Transformation Officer

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok